FDA 483 OBSERVATION · #25 OF 1,945 MOST-CITED
Evaluation - performance, risk
FDA cited this observation 797 times across 724 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this observation means, and how to comply
SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.
The FSVP importer did not adequately evaluate the risk posed by a food and the foreign supplier’s performance — the analysis that sets how the supplier is approved and how intensively it must be verified.
Why FDA writes it — The evaluation of food risk and supplier performance is what makes an FSVP risk-based rather than one-size-fits-all. Skipping or weakening it means verification is not calibrated to the actual hazard, so a high-risk supplier may be verified as lightly as a low-risk one.
- Evaluate the risk posed by the food, using the hazard analysis, and the foreign supplier’s performance in controlling that hazard.
- Consider the supplier’s procedures, processes, and practices, applicable FDA compliance history, and the food’s and supplier’s relevant history.
- Use the evaluation to approve suppliers and to determine appropriate verification activities and frequency.
- Reevaluate when new information about the hazard or supplier performance arises.
- Approving a supplier without a documented evaluation of the food’s risk and the supplier’s performance.
- An evaluation that never feeds the choice of verification activity, so risk and effort are disconnected.
How to close this finding — and stop it recurring
What this observation is associated with
Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.6× the rate of the average FDA-cited firm (12.8% vs 7.8%), across 724 FEI-matched firms.
This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.
How FDA worded it — real examples
You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier's performance and the risk posed by a food.
You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier's performance and the risk posed by a food.
You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier's performance and the risk posed by a food.
You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier's performance and the risk posed by a food.
You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier's performance.
You did not document that you conducted an evaluation or reviewed and assessed an evaluation conducted by another entity to determine a foreign supplier's performance and the risk posed by a food.
Related SPEQ references
Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →